Retinopathy of prematurity and associated factors

International Ophthalmology Clinics

Volumn 39, Issue 2, 1999, Pages 29-48

  Simons, Brad D ^a   Flynn, John T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INDOMETACIN;

ANGIOGENESIS; BIRTH WEIGHT; CLINICAL TRIAL; CRYOTHERAPY; DISEASE SEVERITY; GESTATIONAL AGE; HUMAN; INCIDENCE; LASER SURGERY; MALPRACTICE; MEDICOLEGAL ASPECT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA SURGERY; RETROLENTAL FIBROPLASIA; REVIEW; RISK FACTOR; SCAR FORMATION; UNITED STATES; VISUAL IMPAIRMENT;

BIRTH WEIGHT; CRYOTHERAPY; HUMANS; INCIDENCE; INFANT, NEWBORN; LASER COAGULATION; OPHTHALMOLOGIC SURGICAL PROCEDURES; RETINA; RETINOPATHY OF PREMATURITY; RISK FACTORS; UNITED STATES;

EID: 0032943574     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199903920-00004     Document Type: Review

References (96)

1. Foos RY. Chronic retinopathy of prematurity. Ophthalmology 1985;92:563-574
2. Flynn JT, Bancalari E, Bawol R et al. Retinopathy of prematurity: diagnosis, severity and natural history. Ophthalmology 1987;94:620-629
3. Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. Ophthalmology 1991;98:1628
4. Phelps DL. Retinopathy of prematurity: an estimate of vision loss in the United States-1979. Pediatrics 1981;67:924
5. Phelps DL. Retinopathy of prematurity. Curr Probl Pediatr 1992;22:1
6. Charles JB, Ganthier R Jr, Appiah AP. Incidence and characteristics of retinopathy of prematurity in a low-income inner-city population. Ophthalmology 1991;98:14-17
7. Ashton NW. Oxygen and the growth and development of retinal vessels. Am J Ophthalmol 1966;62:412-435
8. Flynn JT, Cassady J, Essner D, et al. Fluorescein angiogram in retrolental fibroplasia: experience from 1969-1971. Ophthalmology 1979;86:1700-1723
9. Michaelson IC. The mode of development of the vascular system of the retina with some observation on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 1949;68:137-180
10. Cogan DG. Development and senescence of the human retinal vasculature. Trans Ophthalmol Soc UK 1963;83:465-489
11. Cogan DG, Kuwabara T. Accessory cells and vessels of the perinatal human retina. Arch Ophthalmol 1986;104:747-752
12. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 1984;102:1130-1134
13. Committee for the Classification of the Late Stages of Retinopathy of Prematurity. An international classification of retinopathy of prematurity: II. The classification of retinal detachment. Arch Ophthalmol 1987;105:906-912 (published erratum in Arch Ophthalmol 1987;105:1498)
14. Flynn JT, O'Grady GE, Herrera J, et al. Retrolental fibroplasia: I. Clinical observations. Arch Ophthalmol 1977;95:217-223
15. Kushner BJ. Strabismus arid amblyopia associated with regressed retinopathy of prematurity. Arch Ophthalmol 1982;100:256-261
16. Ben-Sira I, Nissenkorn I, Weinberger D, et al. Long-term results of cryotherapy for active stages of retinopathy of prematurity. Ophthalmology 1987;93(11):1423-1428
17. Schaffer DB, Quinn GE, Johnson L. Sequelae of arrested mild retinopathy of prematurity. Arch Ophthalmol 1984;102:373-377
18. Stark DJ, Manning LM, Lenton L. Retrolental fibroplasia today. Med J Aust 1981;1:278-280
19. Arroc M, Peitersen B. Retinopathy of prematurity: review of a seven-year period in a Danish neonatal intensive care unit. Acta Paediatr 1994;83:501-505
20. Darlow BA, Horwood LJ, Clemett RS. Retinopathy of prematurity: risk factors in a prospective population-based study. Paediatr Perinatal Epidemiol 1992;6:62-80
21. Feeney L, Berman, ER. Oxygen toxicity: membrane damage by free radicals. Invest Ophthalmol 1976;15:789-792
22. Fridovich L. The biology of oxygen radicals. Science 1978;201:875-880
23. Katz ML, Robson WG. Autooxidative damage to the retina: potential role in retinopathy of prematurity. Birth Defects 1988;24(1):237-248
24. Tailoi CL, Gock B, Stone J. Supplemental oxygen therapy: basis for noninvasive treatment of retinopathy of prematurity. Invest Ophthalmol Vis Sci 1995;36:1215-1230
25. Rothman KJ. Causes. Am J Epidemiol 1976;104:587-592
26. 2. ROP Conf Proc 1981;1:20-45
27. Flowers R, Blake DA, Waser S. Retrolental fibroplasia: evidence for a role of the prostaglandin cascade in the pathogenesis of oxygen-induced retinopathy in the newborn beagle. Pediatr Res 1982;15:1293-1302
28. Hickam JB, Fraser R. Studies on the retinal circulation in man: observations on vessel diameter, arteriovenous oxygen difference and mean circulation time. Circulation 1966;33:302-316
29. 2 on relative retinal blood flow in monkeys. Invest Ophthalmol 1973;12:335-347
30. 2 and retrolental fibroplasia (RLF). Pediatr Res 1981;15:649
31. Biglan AW, Brown DR, Reynolds JD, Milley J. The interrelationship of blood oxygen, carbon dioxide and pH level and the production of retrolental fibroplasia. Ophthalmology 1984;91:1504-1511
32. Brown DR, Biglan AW, Stretavsky M. Screening criteria for the detection of retinopathy of prematurity in patients in a neonatal intensive care unit. J Pediatr Ophthalmol Strabismus 1987;24:212-215
33. Holmes JM, Duffner LA, Kappil JC. The effect of raised inspired carbon dioxide on developing rat retinal vasculature exposed to elevated oxygen. Curr Eye Res 1994;13:779-782
34. Owens WC, Owens EU. Retrolental fibroplasia in premature infants: II. Studies on the prophylaxis of the disease. The use of alpha-tocopherol acetate. Am J Ophthalmol 1949;32:1631-1637
35. Kinsey VE, Chisholm JF. Retrolental fibroplasia: evaluation of several changes in dietary supplements of premature infants with respect to the incidence of the disease. Am J Ophthalmol 1951;34:1259-1268
36. Johnson LH, Schaffer DB, Goldstein DE. Influence of vitamin E treatment and adult blood transfusion on mean severity of retrolental fibroplasia in premature infants. Pediatr Res 1971;11:534
37. Phelps DL, Rosenbaum AL. Vitamin E protection in experimental retrolental fibroplasia in kittens. Clin Res 1976;24:194(N)
38. Finer NN, Schindler RE, Grant G, Peters K. Effect of intramuscular vitamin E on the frequency and severity of retrolental fibroplasia: a controlled trial. Lancet 1982;1:1087
39. Hittner HM, Godio LB, Rudolph AJ, et al. Retrolental fibroplasia: efficacy of vitamin E in a double blind clinical study of pre-term infants. N Engl J Med 1981;305:1365-1371
40. Milner RA, Watts JL, Paes B, Zipursky B. Retrolental fibroplasia in 1500 gm neonates: part of a randomized clinical trial of effectiveness of vitamin E. ROP Conf Proc 1981;2:703-716
41. Puklin JE, Simon RM, Ehrenkrantz RA. Influence on retrolental fibroplasia of intramuscular vitamin E during respiratory distress syndrome. Ophthalmology 1982; 89:96-103
42. Phelps DL. Vitamin E and retrolental fibroplasia in 1982. Pediatrics 1982;70:430-434
43. Biesel WR, Edelman R, Nauss K, et al. Single nutrient effects on immunologic functions: report of a workshop sponsored by the Department of Food and Nutrition Advisory Group of the American Medical Association. JAMA 1981;245:53-58
44. Prasad JS. Effect of vitamin E supplementation on leukocyte function. Am J Clin Nutr 1980;33:606-608
45. Johnson L, Bowen FW, Abassi S, et al. Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less. Pediatrics 1985;4:619-638
46. Smith TJ, Buchanan MF, Goss I. Vitamin E in retrolental fibroplasia. N Engl J Med 1983;390:669-670
47. Sun XC, Aranda Z, Kaintorn V, Caputo A. Indomethacin and retrolental fibroplasia. ROP Conf Proc 1981;2:522-525
48. Gersony WM, Peckham GJ, Ellison RC. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983;102:895-906
49. Majima A. Problems on retinopathy of prematurity: statistical analysis of factors related to occurrence and progression of retinopathy and fundus appearance and ocular functions in prematurely born subjects. Jpn J Ophthalmol 1977;21:404-420
50. Aranda JV, Clark, TE, Maniello R, Outerbridge E. Blood transfusions: possible potentiating risk factor in retrolental fibroplasia. Pediatr Res 1975;9:362
51. Clark C, Gibbs JH, Maniello R, et al. Blood transfusions: a possible risk factor in retrolental fibroplasia. Acta Paediatr Scand 1971;70:535-543
52. Johnson L, Scharfer DB, Boggs T. The premature infant, vitamin E deficiency and retrolental fibroplasia. Am J Clin Nutr 1974;27:1158-1171
53. Mittleman D, Cronin C. Relationship of blood transfusion and retrolental fibroplasia. ROP Conf Proc 1981;2:526-535
54. Sacks LM, Schaffer DB, Anday EK, et al. Retrolental fibroplasia and blood transfusion in very low birthweight infants. Pediatrics 1981;68:770-774
55. Repka MX, Hudak ML, Parsa CF, Tielsch JM. Calf lung surfactant extract prophylaxis and retinopathy of prematurity. Ophthalmology 1992;99:531-536
56. Repka MX, Hardy RJ, Phelps DL, Summers CG. Surfactant prophylaxis and retinopathy of prematurity. Arch Ophthalmol 1993;111:681-620
57. Holmes JM, Cronin CM, et al. Randomized clinical trial of surfactant prophylaxis in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 1994;31:189-191
58. Glass P, Avery GB, Subramanian KN, et al. Effect of bright light in the hospital nursery on the incidence of retinopathy of prematurity. N Engl J Med 1985;333:401-404
59. Lakatos L, Harvani I, Oroszlan G, et al. Controlled trial of D-penicillamine to prevent retinopathy of prematurity. Acta Paediatr Hung 1986;27(1):47-56
60. Baerts W, Wildervanck de Blecourt-Devilee M, Sauer PJ. Ambient light, ophthalmic artery blood flow velocities and retinopathy of prematurity. Acta Paediatr 1993;82:719-722
61. Seiberth V, Linderkamp O, Knorz MC, Liesenhoff H. A controlled clinical trial of light and retinopathy of prematurity. Am J Ophthalmol 1994;118:492-495
62. Reynolds JD, Hardy RJ, Kennedy KA, et al. Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med. 1998;338(22):1572-1576
63. Charles S. Vitreous surgery for retinopathy of prematurity (ROP). ROP Conf Proc 1981;2:858-863
64. Charles S. Vitreous microsurgery. Baltimore: Williams & Wilkins, 1981:159-160
65. Hirose T, Schepens CL, Lopansri C. Subtotal open sky vitrectomy for severe retinal detachment occurring as a late complication of ocular trauma. Ophthalmology 1981;88:1-9
66. Machemer R. Closed vitrectomy for severe retrolental fibroplasia in the infant. Ophthalmology 1983;90:426-441
67. Machemer R. Description and pathogenesis of late stages of retinopathy of prematurity. Ophthalmology 1985;92:1000-1004
68. Paulman H. Pars plana vitrectomy in retrolental fibroplasia. ROP Conf Proc 1981;2:893-902
69. Tasman W. Late complications of retrolental fibroplasia. Ophthalmology 1979;86:1724-1740
70. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multi-center trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988;106:471-479
71. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multi-center trial of cryotherapy for retinopathy of prematurity: three-month outcome. Arch Ophthalmol 1990;108:195-204
72. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multi-center trial of cryotherapy for retinopathy of prematurity: one-year outcome. Arch Ophthalmol 1990;108:1408-1416
73. Cryotherapy for Retinopathy of Prematurity Cooperative Group. The natural ocular outcome of premature birth and retinopathy, status at 1 year. Arch Ophthalmol 1994;112:903-912
74. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multi-center trial of cryotherapy for retinopathy of prematurity: Snellen visual acuity and structural outcome at 51/2 years after randomization. Arch Ophthalmol 1996;114:417-424
75. Reynolds J, Dobson V, Quinn GE, et al. Prediction of visual function in eye with mild to moderate posterior pole residua of retinopathy of prematurity. Arch Ophthalmol 1993;111:1050-1056
76. Dobson V, Quinn GE, Summers CG, et al. Effect of acute-phase retinopathy of prematurity on grating acuity development in the very low birth weight infant. Invest Ophthalmol Vis Sci 1994;35:4236-4244
77. Dobson V, Quinn GE, Tung B, et al. Comparison of recognition and grating acuities in very-low-birth-weight children with and without retinal residua of retinopathy of prematurity. Invest Ophthalmol Vis Sci 1995;36:692-702
78. Dobson V, Quinn GE, Saunders RA, et al. Grating visual acuity in eyes with retinal residua of retinopathy of prematurity. Arch Ophthalmol 1995;113:1172-1177
79. Quinn GE, Dobson V, Biglan A, et al. Correlation of retinopathy of prematurity in fellow eyes in the cryotherapy for retinopathy of prematurity. Arch Ophthalmol 1995;113:469-473
80. Kivlin JD, Biglan AW, Gordon RA, et al. Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Arch Ophthalmol 1996;114:150-154
81. Kremer I, Nissenkorn I, Lusky M, Yassur Y. Late visual field changes following cryotherapy for retinopathy of prematurity stage 3. Br J Ophthalmol 1995;79:267-269
82. Quinn GE, Dobson V, Hardy RJ, et al. Visual fields measured with double-arc perimetry in eyes with threshold retinopathy of prematurity from the cryotherapy for retinopathy of prematurity trial. The CRYO-Retinopathy of Prematurity Cooperative Group. Ophthalmology 1996;103:1432-1437
83. Dobson V, Quinn GE, Abramov I, et al. Color vision measured with pseudoisochromatic plates at five-and-a-half years in eyes of children from the CRYO-ROP study. Invest Ophthalmol Vis Sci 1996;37(12):2467-2474
84. McNamara, JA, Tasman, W, Brown, GC, Federman JL. Laser photocoagulation for stage 3+ retinopathy of prematurity. Ophthalmology 1991;98:576-580
85. BennerJD, Huang M, Morse LS, et al. Comparison of photocoagulation with the argon, krypton, and diode laser indirect ophthalmoscopes in rabbit eyes. Ophthalmology 1992;99:1554-1563
86. McNamara JA, Tasman W, Vander JF, Brown GC. Diode laser photocoagulation for retinopathy of prematurity. Arch Ophthalmol 1992;110:1714-1716
87. Hunter DG, Repka MX. Diode laser photocoagulation for threshold retinopathy of prematurity. Ophthalmology 1993;100:238-244
88. Capone A, Diaz-Rohena R, Sternberg P Jr, et al. Diode-laser photocoagulation for zone I threshold retinopathy of prematurity. Am J Ophthalmol 1993;116:444-450
89. Goggin M, O'Keefe M. Diode laser for retinopathy of prematurity - early outcome. Br J Ophthalmol 1993;77:559-562
90. Fleming TN, Runge PE, Charles ST. Diode laser photocoagulation for prethreshold, posterior retinopathy of prematurity. Am J Ophthalmol 1992;114:589-592
91. Simons BD, Wilson MC, Hertle RW, Schaffer DB. Bilateral hyphemas and cataracts after diode laser retinal photoablation for retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 1998;35:185-187
92. Drack AV, Burkej P, Pulicloj S, Keech RV. Transient punctate lenticular opacities as a complication of argon laser photoablation in an infant with retinopathy of prematurity [letter]. AmJ Ophthalmol 1992;113:583-584
93. Christiansen SP, Bradford JD. Cataract in infants treated with argon laser photocoagulation for threshold retinopathy of prematurity. Am J Ophthalmol 1995;119:175-180
94. Trese MT. Scleral buckling for retinopathy of prematurity. Ophthalmology 1994;101:23-26
95. Seaber JH, Machemer R, Eliott D, et al. Long-term visual results of children after initially successful vitrectomy for stage V retinopathy of prematurity. Ophthalmology 1995;102:199-204
96. Quinn GE, Dobson V, Repka MX, et al. Development of myopia in infants with birth weights less than 1251 grams. Ophthalmology 1992;99:329-340